 Study results to be presented at the 14th International Conference on Advanced Technologies and Treatments for Diabetes NEW YORK, June 4, 2021 PRNewswire -- DarioHealth Corp. NASDAQ: DRIO, a leader in the global digital therapeutics DTx market, announced today it will be presenting results of a new study at the 14th International Conference on Advanced Technologies and Treatments for Diabetes ATTD 2021; June 2-5, 2021. The study, titled Impact of Digital Intervention Engine on Diabetes Self-Management, examined the effect of DarioHealths highly personalized digital journeys on both clinical and engagement outcomes, applying user-specific digital intervention flows for behavioral change to increase user digital engagement. 